Literature DB >> 35320453

MiR-125b-5p/TPD52 Axis Affects Proliferation, Migration and Invasion of Breast Cancer Cells.

Jun Fang1, Yuezhen Wang2,3, Feiying Gu1.   

Abstract

Aberrant gene expression caused by miRNAs disorders plays a relevant role in multiple steps of tumorigenesis. In this attempt, we studied the functional role of miR-125b-5p and TPD52 in breast cancer. TPD52 mRNA and miR-125b-5p levels were assessed via qRT-PCR, and TPD52 protein level was analyzed via western blot. By performing CCK-8, transwell invasion and wound healing assays, the phenotype changes in breast cancer cells were assessed. miR-125b-5p was proven as an upstream miRNA of TPD52 in breast cancer via TargetScan database, luciferase activity, and western blot. MiR-125b-5p was prominently decreased while TPD52 was dramatically increased in breast cancer cells. Functional assays exhibited that forced level of TPD52 facilitated cell proliferation, invasion and migration in breast cancer. In the end, the rescue assay proved that miR-125b-5p was a cancer repressor and modulated breast cancer progression by targeting TPD52. All above offer potential biomarkers for breast cancer treatment.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Breast cancer; Invasion; Migration; Proliferation; TPD52; miR-125b-5p

Mesh:

Substances:

Year:  2022        PMID: 35320453     DOI: 10.1007/s12033-022-00475-3

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.860


  25 in total

1.  Silencing of TPD52 inhibits proliferation, migration, invasion but induces apoptosis of pancreatic cancer cells by deactivating Akt pathway.

Authors:  Z Wang; Y Li; L Fan; Q Zhao; B Tan; R Liu; F Li
Journal:  Neoplasma       Date:  2019-12-17       Impact factor: 2.575

Review 2.  Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials.

Authors:  Everardo D Saad; Artur Katz; Marc Buyse
Journal:  J Clin Oncol       Date:  2010-03-01       Impact factor: 44.544

3.  microRNA-218 inhibits prostate cancer cell growth and promotes apoptosis by repressing TPD52 expression.

Authors:  Guangye Han; Maochuan Fan; Xinjun Zhang
Journal:  Biochem Biophys Res Commun       Date:  2014-12-13       Impact factor: 3.575

4.  Altered expression of tumor protein D52 regulates apoptosis and migration of prostate cancer cells.

Authors:  Ramesh Ummanni; Steffen Teller; Heike Junker; Uwe Zimmermann; Simone Venz; Christian Scharf; Jürgen Giebel; Reinhard Walther
Journal:  FEBS J       Date:  2008-11       Impact factor: 5.542

5.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396

Review 6.  Cancer drug resistance: an evolving paradigm.

Authors:  Caitriona Holohan; Sandra Van Schaeybroeck; Daniel B Longley; Patrick G Johnston
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

7.  miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52.

Authors:  Hong Chen; Hong Xu; Yu-Gang Meng; Yun Zhang; Jun-Ying Chen; Xiao-Ning Wei
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

8.  Tumor Protein D52 (TPD52) Inhibits Growth and Metastasis in Renal Cell Carcinoma Cells Through the PI3K/Akt Signaling Pathway.

Authors:  Zhenhua Zhao; Hui Liu; Junqing Hou; Tieqiang Li; Xinyi Du; Xiaolei Zhao; Wenchao Xu; Weibo Xu; Junkai Chang
Journal:  Oncol Res       Date:  2016-11-08       Impact factor: 5.574

9.  The four-transmembrane protein MAL2 and tumor protein D52 (TPD52) are highly expressed in colorectal cancer and correlated with poor prognosis.

Authors:  Jingwen Li; Yongmin Li; He Liu; Yanlong Liu; Binbin Cui
Journal:  PLoS One       Date:  2017-05-31       Impact factor: 3.240

10.  Knockdown of lncRNA PCAT6 Enhances Radiosensitivity in Triple-Negative Breast Cancer Cells by Regulating miR-185-5p/TPD52 Axis.

Authors:  Rui Shi; Peng Wu; Miaomiao Liu; Bing Chen; Longjiao Cong
Journal:  Onco Targets Ther       Date:  2020-04-08       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.